Anindita Chanda

ORCID: 0000-0002-8543-7978
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Surgical Oncology
  • Genetic Neurodegenerative Diseases
  • Dysphagia Assessment and Management
  • Head and Neck Cancer Studies
  • Mitochondrial Function and Pathology
  • Cardiac Imaging and Diagnostics
  • Advanced X-ray and CT Imaging
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Medical Imaging Techniques and Applications
  • Cardiac Structural Anomalies and Repair
  • Lung Cancer Treatments and Mutations
  • Mechanical Circulatory Support Devices
  • Lung Cancer Research Studies
  • Acute Ischemic Stroke Management
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Ultrasound in Clinical Applications
  • Heart Failure Treatment and Management
  • Neurological disorders and treatments
  • Alcoholism and Thiamine Deficiency

University of Connecticut
2023-2025

Boston Medical Center
2024

UConn Health
2024

Touro College
2022

Lung cancer is the second most common worldwide and leading cause of cancer-related death. While survival rates have improved with advancements in therapeutics, additional health challenges surfaced. Cardiovascular disease (CVD) a morbidity mortality patients lung cancer. CVD share many risk factors, such as smoking, hypertension, diabetes, advanced age, obesity. Optimal management this patient population requires full understanding potential cardiovascular (CV) complications treatment. This...

10.3389/fonc.2024.1258991 article EN cc-by Frontiers in Oncology 2024-02-12

ABSTRACT Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder with a broad spectrum of systemic manifestations, including cardiac abnormalities. Takotsubo cardiomyopathy, form stress‐induced transient heart failure, not typically associated DM1, and its occurrence in this patient population remains poorly characterized. This case series aims to describe two instances cardiomyopathy patients highlighting potential links between the neuromuscular pathophysiology DM1...

10.1002/ajmg.a.64027 article EN American Journal of Medical Genetics Part A 2025-02-25

Background Severe cardiac cachexia or malnutrition are commonly considered relative contraindications to left ventricular assist device (LVAD) implantation, but post-LVAD prognosis for patients with is uncertain. Methods and Results Intermacs (Interagency Registry Mechanically Assisted Circulatory Support) 2006 2017 was queried the preimplantation variable cachexia/malnutrition. Cox proportional hazards modeling examined relationship between LVAD outcomes. Of 20 332 primary recipients...

10.1161/jaha.122.029086 article EN cc-by-nc-nd Journal of the American Heart Association 2023-06-29

Background Authoritative research demonstrating efficacy of traditional dysphagia therapy for Head & Neck Cancer (HNC) patients is limited. A 2019 survey reported speech-language-pathologists (SLPs) have started using Manual Therapy (MT) to prevent or rehabilitate in HNC patients. This application MT supported theoretically but no has established efficacy. Further, specific contents protocols employed this setting remain unknown. Objectives In the absence protocols, study aimed better...

10.1177/27536130241263349 article EN Global Advances in Integrative Medicine and Health 2024-01-01

Myotonic dystrophy type 1 (MD1) is an autosomal dominant neuromuscular disease that can affect skeletal, smooth, and cardiac muscle. Patients often have involvement such as conduction diseases, ventricular arrhythmia, sudden death, cardiomyopathy pulmonary hypertension. We describe a patient with MD1 who suffered recurrent takotsubo cardiomyopathy. Case: A 39-year-old female history of myotonic 1, recovered ejection fraction (EF) 50-55%, gastroparesis orthostatic hypotension presented chest...

10.1161/circ.148.suppl_1.14154 article EN Circulation 2023-11-07
Coming Soon ...